findmyKOL
Clinical trialNCT06937086RecruitingPhase 3Interventional

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

SponsorEli Lilly and CompanyEnrollment350Obesity or OverweightUlcerative Colitis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide, compared with treatment with mirikizumab and placebo, leads to decrease or disappearance of UC symptoms, and loss of at least one-tenth of the overall body weight. Participation in this study will last up to 61 weeks, including 52 weeks of treatment.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Eli Lilly and Company

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

188 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • Medizinische Universität Graz

    Graz, Austria

    Christoph Hoegenauer
    Recruiting
  • Medizinische Universitaet Innsbruck

    Innsbruck, Austria

    Robert Koch
    Recruiting
  • Medizinische Universität Wien

    Vienna, Austria

    Walter Reinisch
    Recruiting
Belgium
  • Azorg Campus Aalst-Moorselbaan

    Aalst, Belgium

    Stijn Vanden Branden
    Recruiting
  • Université Libre de Bruxelles - Hôpital Erasme

    Brussels, Belgium

    Denis Franchimont
    Recruiting
  • Az Groeninge Campus Kennedylaan

    Kortrijk, Belgium

    Wouter Van Moerkercke
    Recruiting
  • Uz Leuven

    Leuven, Belgium

    João Guedelha Sabino
    Recruiting
  • Centre Hospitalier Universitaire de Liège - Domaine Universitaire Du Sart Tilman

    Liège, Belgium

    Edouard Louis
    Recruiting
  • Clinical Chc Montlégia

    Liège, Belgium

    Arnaud Colard
    Recruiting
Brazil
  • Newdata Clinical Research - Aracaju

    Aracaju, Brazil

    Alex Callado França
    Recruiting
  • L2ip - Instituto de Pesquisas Clínicas

    Brasília, Brazil

    Luciana Teixeira de Campos
    Recruiting
  • Loema Instituto de Pesquisa Clinica

    Campinas, Brazil

    Joaquim Simoes Neto
    Recruiting
  • Fundação Universidade de Caxias Do Sul (fucs)

    Caxias do Sul, Brazil

    Eduardo Brambilla
    Recruiting
  • Centro Digestivo de Curitiba

    Curitiba, Brazil

    Odery Ramos Júnior
    Recruiting
  • Galileo Medical Research

    Juiz de Fora, Brazil

    Julio Chebli
    Recruiting
  • Hospital de Clinicas de Porto Alegre

    Porto Alegre, Brazil

    Luciana Harlacher
    Recruiting
  • Hospital de Clínicas de Ribeirão Preto

    Ribeirão Preto, Brazil

    Rogerio Parra
    Recruiting
  • Cliagen Clínica de Atenção Em Gastroenterologia, Especialidades E Nutrição

    Salvador, Brazil

    Genoile Silva
    Recruiting
  • Pesquisare Saude

    Santo André, Brazil

    ALEXANDER DE SA ROLIM
    Recruiting
  • Cepic - Centro Paulista de Investigação Clínica

    São Paulo, Brazil

    Breno Balabem Alves
    Recruiting
  • Cpquali Pesquisa Clínica

    São Paulo, Brazil

    Alexandre de Sousa Carlos
    Recruiting
  • Clínica Hepatogastro Jk

    São Paulo, Brazil

    Rodrigo Andrey Rocco
    Recruiting
  • Cedoes

    Vitória, Brazil

    Felipe Ferreira
    Recruiting
  • Integral Pesquisa E Ensino

    Votuporanga, Brazil

    HERLON VALÉRIO
    Recruiting
Bulgaria
  • University Hospital "st. Ivan Rilski"

    Gorna Oryahovitsa, Bulgaria

    Ilko Kosturkov
    Recruiting
Canada
  • London Digestive Disease Institute

    London, Canada

    Vipul Jairath
    Recruiting
  • London Health Sciences Centre

    London, Canada

    Terry Ponich
    Recruiting
  • Clinique Imd

    Montreal, Canada

    Waqqas Afif
    Recruiting
  • the Ottawa Hospital - General Campus

    Ottawa, Canada

    Jeffrey McCurdy
    Not, yet, recruiting
  • (g.I.R.I.) Gi Research Institute Foundation

    Vancouver, Canada

    Greg Rosenfeld
    Recruiting
  • Vancouver General Hospital

    Vancouver, Canada

    Sundeep Singh
    Not, yet, recruiting
Czechia
  • Surgal Clinic

    Brno, Czechia

    Jan Ulbrych
    Recruiting
  • Gastroenterologie

    Hradec Králové, Czechia

    Milan Siroky
    Recruiting
  • Endoart

    Ostrava, Czechia

    Radka Koskova
    Recruiting
  • Iscare Klinické Centrum

    Prague, Czechia

    Milan Lukas
    Recruiting
  • Restrial Gastroendo S.R.O

    Prague, Czechia

    Ludek Hrdlicka
    Recruiting
  • Masarykova Nemocnice V Usti Nad Labem

    Ústí nad Labem, Czechia

    Michal Tichy
    Recruiting
Denmark
  • Aarhus Universitetshospital, Skejby

    Aarhus, Denmark

    Anders Dige
    Recruiting
  • Herlev and Gentofte Hospital

    Copenhagen, Denmark

    Jacob Bjerrum
    Recruiting
  • Rigshospitalet

    Copenhagen, Denmark

    Anja Poulsen
    Recruiting
148 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Jun 2025
Primary completion
30 Apr 2028
Completion
30 Apr 2028
Last update posted
21 Aug 2026
Registered enrollment
350
Registry id
NCT06937086

Cross-registrations

EU-CTR / CTIS (EudraCT)2024-520209-38-00

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.